Newsletter Archive
-
02.04.26 -- Money In The Bank: Why 2025's Setbacks Were The Foundation RNA Needed
2/4/2026
02/04/26 Advancing RNA Newsletter
-
01.28.26 -- Manufacturing Complexities Stymie In Vivo Progress
1/28/2026
01/28/26 Advancing RNA Newsletter
-
01.21.26 -- Biology, Specificity, And The Rules Of RNA Business Strategy In 2026
1/21/2026
01/21/26 Advancing RNA Newsletter
-
01.07.26 -- Market Trends That Defined mRNA In 2025
1/7/2026
01/07/26 Advancing RNA Newsletter
-
12.23.25 -- Top 10 Of 2025
12/23/2025
12/23/25 Advancing RNA Newsletter
-
12.17.25 -- Critical Discussions Driving The mRNA Industry's Next Chapter
12/17/2025
12/17/25 Advancing RNA Newsletter
-
12.10.25 -- Global Trials And Oncology Insights
12/10/2025
12/10/25 Advancing RNA Newsletter
-
12.08.25 -- The Art of Phosphitylation – Innovating Efficiency In Oligonucleotide Synthesis
12/8/2025
12/08/25 Advancing RNA Newsletter
-
12.03.25 -- CMC Challenges In The Development Of Conjugated LNP Platforms
12/3/2025
12/03/25 Advancing RNA Newsletter
-
12.01.25 -- Your trusted filters made closer to you – try by yourself!
12/1/2025
12/01/25 Advancing RNA Newsletter